Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes
暂无分享,去创建一个
Andrew Ridsdale | John Paul Pezacki | Rodney K. Lyn | R. Oballa | S. Kargman | R. Singaravelu | J. Pezacki | A. Ridsdale | Rodney S. Russell | Daniel M. Jones | S. O’Hara | Renata Oballa | Stacia Kargman | Zheng Huang | A. Partridge | R. Russell | Ragunath Singaravelu | Shifawn O'Hara | Helen Chan | Zheng Huang | Anthony W. Partridge | Helen Chan | R. K. Lyn
[1] Ralf Bartenschlager,et al. A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. , 2003, Journal of virological methods.
[2] Thomas Lengauer,et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.
[3] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[4] G. Alvisi,et al. Hepatitis c virus and host cell lipids: An intimate connection , 2011, RNA biology.
[5] Andrew Ridsdale,et al. Optimally chirped multimodal CARS microscopy based on a single Ti:sapphire oscillator. , 2009, Optics express.
[6] Rodney K. Lyn,et al. Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism. , 2009, Virology.
[7] S Schleich,et al. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. , 2001, Molecular biology of the cell.
[8] P. Escribá,et al. Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.M200356-JLR200 , 2003, Journal of Lipid Research.
[9] J. Mackenzie. Wrapping Things up about Virus RNA Replication , 2005, Traffic.
[10] G. Meer,et al. Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.
[11] M. Aoki,et al. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy , 2005, Nature chemical biology.
[12] Ricardo Macarron,et al. Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase* , 2002, The Journal of Biological Chemistry.
[13] Robert G. Parton,et al. Opinion: Lipid droplets: a unified view of a dynamic organelle , 2006, Nature Reviews Molecular Cell Biology.
[14] R. Oballa,et al. Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.
[15] R. Bartenschlager,et al. The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.
[16] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[17] Soon B. Hwang,et al. Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2 , 2003, Journal of Virology.
[18] M. Ott,et al. Unique ties between hepatitis C virus replication and intracellular lipids , 2011, Trends in Endocrinology & Metabolism.
[19] J. Ntambi,et al. Biochemical and physiological function of stearoyl-CoA desaturase. , 2009, American journal of physiology. Endocrinology and metabolism.
[20] A. D. Smith,et al. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.
[21] L. Wodicka,et al. Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] David A. Powell,et al. Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. , 2011, Journal of medicinal chemistry.
[23] K. Chayama,et al. Hepatitis C Virus Core Protein Modulates Fatty Acid Metabolism and Thereby Causes Lipid Accumulation in the Liver , 2005, Digestive Diseases and Sciences.
[24] J. Falgueyret,et al. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). , 2010, Bioorganic & medicinal chemistry letters.
[25] J. Fontana,et al. Virus factories: associations of cell organelles for viral replication and morphogenesis , 2005, Biology of the cell.
[26] A. Nohturfft,et al. Coordination of lipid metabolism in membrane biogenesis. , 2009, Annual review of cell and developmental biology.
[27] K. Koike,et al. Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein. , 2011, Journal of hepatology.
[28] P. Ahlquist,et al. Mutation of Host Δ9 Fatty Acid Desaturase Inhibits Brome Mosaic Virus RNA Replication between Template Recognition and RNA Synthesis , 2001, Journal of Virology.
[29] R. Oballa,et al. SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors. , 2010, Bioorganic & medicinal chemistry letters.
[30] R. Oballa,et al. Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. , 2011, Bioorganic & medicinal chemistry letters.
[31] A. Siddiqui,et al. Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress , 2007, Journal of Virology.
[32] J. Pawlotsky,et al. Hepatitis C Virus Proteins Induce Lipogenesis and Defective Triglyceride Secretion in Transgenic Mice* , 2009, The Journal of Biological Chemistry.
[33] R. Oballa,et al. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. , 2012, Bioorganic & medicinal chemistry letters.
[34] P. Wydro,et al. The influence of fatty acids on model cholesterol/phospholipid membranes. , 2007, Chemistry and physics of lipids.
[35] D. Lavanchy,et al. Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] Rodney K. Lyn,et al. Dynamics of lipid droplets induced by the hepatitis C virus core protein. , 2010, Biochemical and biophysical research communications.
[37] John Paul Pezacki,et al. Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy , 2011, Nature chemical biology.
[38] John Paul Pezacki,et al. Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. , 2013, Chemistry & biology.
[39] J. Krijnse-Locker,et al. Modification of intracellular membrane structures for virus replication , 2008, Nature Reviews Microbiology.
[40] R. Bartenschlager,et al. Morphological and Biochemical Characterization of the Membranous Hepatitis C Virus Replication Compartment , 2013, Journal of Virology.
[41] D. Hazuda,et al. Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System , 2011, Antimicrobial Agents and Chemotherapy.
[42] D. Olsen,et al. A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations. , 2008, Analytical biochemistry.
[43] J. Ntambi. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. , 1999, Journal of lipid research.
[44] Rodney K. Lyn,et al. Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem. , 2010, Molecular bioSystems.
[45] J. Auwerx,et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. , 2005, Gastroenterology.
[46] K. Shimotohno,et al. Hepatitis C Virus Non-structural Proteins in the Probable Membranous Compartment Function in Viral Genome Replication* , 2003, Journal of Biological Chemistry.
[47] Lawrence C Kuo,et al. Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs* , 2003, The Journal of Biological Chemistry.
[48] P. Ahlquist,et al. Membrane-shaping host reticulon proteins play crucial roles in viral RNA replication compartment formation and function , 2010, Proceedings of the National Academy of Sciences.
[49] Min Jung Park,et al. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. , 2007, Biochemical and biophysical research communications.
[50] Darius Moradpour,et al. A Dynamic View of Hepatitis C Virus Replication Complexes , 2008, Journal of Virology.
[51] Simon C Watkins,et al. Fatty acid synthase is up‐regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production , 2008, Hepatology.
[52] S. Emerson,et al. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.
[53] Johannes P. Schlöder,et al. Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle , 2013, PLoS pathogens.
[54] Rodney K. Lyn,et al. Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis , 2014, Hepatology.
[55] Ralf Bartenschlager,et al. Architecture and biogenesis of plus-strand RNA virus replication factories. , 2013, World journal of virology.